Source:http://linkedlifedata.com/resource/pubmed/id/12472720
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11-12
|
pubmed:dateCreated |
2002-12-10
|
pubmed:abstractText |
Different commercial enzyme-linked immunsorbent assays (ELISA) were evaluated in a preliminary study for diagnosis of systemic candidosis: Biomerica and Virotech GmbH, which allowed immunoglobulin G detection, and Platelia, which associated total antibody to antigen detection. They were tested with a home-made ELISA and compared with the routine techniques used in the hospital laboratory: indirect immunofluorescence and counter-immunoelectrophoresis. Sera were obtained from patients with probable or proven systemic candidosis (groups 3 and 4, n=8 and n=14, respectively) and from patients without systemic candidosis who were divided into controls (n=10), those hospitalized without Candida isolation (group 1, n=10) and those hospitalized with Candida isolation in a peripheral site (group 2, n=18). The immunoglobulin G ELISAs showed a higher sensitivity associated with lower specificity compared to the indirect immunofluorescence, counter-immunoelectrophoresis and total immunoglobulin ELISAs. Mannan antigen detection showed the highest specificity (78.9%). Its association with the detection of total anti-Candida immunoglobulins was more sensitive than the association of indirect immunofluorescence with counter-immunoelectrophoresis (95.4% versus 59%, respectively) with a specificity of 52.6% (versus 55.2%). Interest in the use of commercial ELISAs, more particularly the Platelia tests, has to be confirmed in a prospective study with follow-up of the patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0933-7407
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
455-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12472720-Antibodies, Fungal,
pubmed-meshheading:12472720-Antigens, Fungal,
pubmed-meshheading:12472720-Candida,
pubmed-meshheading:12472720-Candida albicans,
pubmed-meshheading:12472720-Candidiasis,
pubmed-meshheading:12472720-Counterimmunoelectrophoresis,
pubmed-meshheading:12472720-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12472720-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:12472720-Fungemia,
pubmed-meshheading:12472720-Humans,
pubmed-meshheading:12472720-Reagent Kits, Diagnostic,
pubmed-meshheading:12472720-Sensitivity and Specificity
|
pubmed:year |
2002
|
pubmed:articleTitle |
Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis.
|
pubmed:affiliation |
Service de Parasitologie, Mycologie Médicale et Maladies Tropicales, and Service d'Hématologie, Hôpital Edouard Herriot, Lyon, France. florence.persat@Univ-lyon.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|